Literature DB >> 10090173

Bone density and bone turnover in patients with osteoarthritis and osteoporosis.

A Stewart1, A Black, S P Robins, D M Reid.   

Abstract

OBJECTIVE: Osteoarthritis (OA) and osteoporosis (OP) are reported to be rare in the same patient. We examined bone mass, bone turnover, and radiological presence of OA in a group of patients with OA with previous hip fractures and age matched controls.
METHODS: Bone mass was assessed by bone mineral density (BMD), using dual energy x-ray absorptiometry (DEXA) of the hip and total body, and quantitative ultrasound of the os calcis, measuring broadband ultrasound attenuation and velocity of sound. Bone turnover was assessed by measuring urinary pyridinium crosslinks and serum osteocalcin.
RESULTS: There were differences in bone density, the patients with OP having lower bone density, while patients with OA had similar or increased bone density compared to controls, Serum osteocalcin showed no significant differences among the 3 groups of patients. Urinary pyridinium crosslinks excretion was significantly elevated in the OA group but not in the OP group compared with controls.
CONCLUSION: Increased bone turnover was restricted to the OA group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090173

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Authors:  P Garnero; M Piperno; E Gineyts; S Christgau; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Bone mineral density distribution in the proximal femur and its relationship to morphologic factors in progressed unilateral hip osteoarthritis.

Authors:  Naomi Kobayashi; Yutaka Inaba; Yohei Yukizawa; Shu Takagawa; Hiroyuki Ike; So Kubota; Takuma Naka; Tomoyuki Saito
Journal:  J Bone Miner Metab       Date:  2014-12-03       Impact factor: 2.626

3.  The relationship between knee osteoarthritis and osteoporosis.

Authors:  Ilhan Sezer; Ozge G Illeez; Serpil D Tuna; Nilufer Balci
Journal:  Eurasian J Med       Date:  2010-12

4.  Users of oestrogen replacement therapy have more knee cartilage than non-users.

Authors:  A E Wluka; S R Davis; M Bailey; S L Stuckey; F M Cicuttini
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 5.  What is the utility of biomarkers for assessing the pathophysiology of hip osteoarthritis? A systematic review.

Authors:  Jeffrey J Nepple; Kayla M Thomason; Tonya W An; Marcie Harris-Hayes; John C Clohisy
Journal:  Clin Orthop Relat Res       Date:  2015-05       Impact factor: 4.176

Review 6.  Osteoarthritis and bone mineral density: are strong bones bad for joints?

Authors:  Sarah A Hardcastle; Paul Dieppe; Celia L Gregson; George Davey Smith; Jon H Tobias
Journal:  Bonekey Rep       Date:  2015-01-21

7.  Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis.

Authors:  P Garnero; T Conrozier; S Christgau; P Mathieu; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

Review 8.  Osteoarthritis: understanding the pathophysiology, genetics, and treatments.

Authors:  Vladamir Sinkov; Tyler Cymet
Journal:  J Natl Med Assoc       Date:  2003-06       Impact factor: 1.798

9.  The effects of bone turnover rate on subchondral trabecular bone structure and cartilage damage in the osteoarthritis rat model.

Authors:  Young Hwan Koh; Sung Hwan Hong; Heung Sik Kang; Chin Youb Chung; Kyung-Hoi Koo; Hye Won Chung; Joo Hee Cha; Kyu Ri Son
Journal:  Rheumatol Int       Date:  2009-08-27       Impact factor: 2.631

10.  A method for assessment of the shape of the proximal femur and its relationship to osteoporotic hip fracture.

Authors:  J S Gregory; D Testi; A Stewart; P E Undrill; D M Reid; R M Aspden
Journal:  Osteoporos Int       Date:  2003-11-07       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.